Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure

Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure

 

The purpose of this study is to determine whether 60-minute sessions of prolonged exposure (PE) are as effective as the standard 90-minute session for treating posttraumatic stress disorder (PTSD). Participants will include patients ages 18 or older with a current diagnosis of PTSD who are seeking treatment in our clinic. Patients who have current substance dependence, psychosis, and suicidal ideation with intent and plan may not be suitable for receiving PE and may be offered another treatment or referred to a different treatment center. Participants will be randomized to receive either the 90- minute or 60-minute PE session. A blind evaluator will assess for pre-treatment, post-treatment, and follow-up levels of symptom severity using the PTSD Symptoms Scale Interview (PSS-I). Participants will attend weekly treatment sessions with any of our faculty members and will complete self-report measures at every session (see below).

 

 Eligibility
 

Ages Eligible for Study:  

18 Years and older   (Adult, Senior)

Sexes Eligible for Study:  

All

Accepts Healthy Volunteers:  

No

Criteria

Inclusion Criteria:

·         Primary diagnosis of PTSD

·         Recommended by therapist to receive Prolonged Exposure therapy

Exclusion Criteria:

·         Current substance dependence, psychosis, suicidal ideation with intent and plan, or other psychiatric problems warranting immediate clinical attention or would interfere with Prolonged Exposure therapy

 

 Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies. 

Please refer to this study by its ClinicalTrials.gov identifier: NCT01911585
 

Contacts

Contact: Hayley Fitzgerald, B.A.

215-746-3327

fhayley@mail.med.upenn.edu

Contact: Lily Brown, Ph.D.

215-746-3327

lilybr@mail.med.upenn.edu
 

Locations

United States, Pennsylvania

Center for the Treatment and Study of Anxiety

Recruiting

PhiladelphiaPennsylvaniaUnited States, 19106

Contact: Hayley Fitzgerald, B.A.    215-746-3327    fhayley@mail.med.upenn.edu   

Contact: Lily Brown, Ph.D.    215-746-3327    lilybr@mail.med.upenn.edu   

Principal Investigator: Edna B. Foa, Ph.D.         

Sub-Investigator: Lily Brown, Ph.D.         

Sponsors and Collaborators

University of Pennsylvania

Investigators

Principal Investigator:

Edna B. Foa, Ph.D.

University of Pennsylvania